Antibody

612개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved612 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleMedical University of ViennaPhase 2

atezolizumab (Tecentriq, FMT combined with Atezolizumab plus Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Medical
Trials 1Status Active
AntibodyLimited DatastaleNanogen Pharmaceutical Biotechn…Phase 3

Faceptor (Faceptor)

Breast Cancer Metastatic; Breast Cancer Recurrent · Breast Cancer Metastatic

#BreastCancerMetastatic#Antibody#Phase3#monoclonal-antibody#BreastCancerRecurrent+1
Trials 1Status Active
AntibodyLimited DatastaleGeneMedicine Co., Ltd.Phase 2

Part C (GM103 and Pembrolizumab, GM103 and Pembrolizumab (Part C))

Head and Neck Cancer; Malignant Melanoma · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#monoclonal-antibody#MalignantMelanoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbViePhase 3

adalimumab biosimilar (GP2017, GP2017 (adalimumab biosimilar))

Ankylosing Spondylitis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleSandozPhase 3

adalimumab (Humira, GP2017 Adalimumab)

Plaque Type Psoriasis · Plaque Type Psoriasis

#PlaqueTypePsoriasis#Antibody#Phase3#monoclonal-antibody#Sandoz
Trials 1Status Active
AntibodyLimited DatastaleGlenmark Specialty S.A.Phase 1

atezolizumab (Tecentriq, GRC 54276 + Atezolizumab)

Advanced Solid Tumor; Lymphoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#Lymphoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleGlenmark Specialty S.A.Phase 1

pembrolizumab (Keytruda, GRC 54276 + Pembrolizumab)

Advanced Solid Tumor; Lymphoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#Lymphoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleQuantumLeap Healthcare Collabor…Phase 2

GSK 5733584 + Dostarlimab (GSK 5733584 + Dostarlimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Recruiting
AntibodyLimited DatastaleSuzhou Kintor Pharmaceutical In…Phase 2

nivolumab (Opdivo, GT90001 and Nivolumab)

Metastatic Hepatocellular Carcinoma; HCC · Metastatic Hepatocellular Carcinoma

#MetastaticHepatocellularCarcinom#Antibody#Phase2#monoclonal-antibody#HCC+1
Trials 1Status Active
AntibodyLimited DatastaleInsel Gruppe AG, University Hos…Phase 2

durvalumab (Imfinzi, Gemcitabin, Cisplatin and Durvalumab)

Bile Duct Cancer · Bile Duct Cancer

#BileDuctCancer#Antibody#Phase2#monoclonal-antibody#Insel
Trials 1Status Recruiting
AntibodyLimited DatastaleSeoul National University Hospi…Phase 2

nivolumab (Opdivo, Gemcitabine+ nivolumab)

Recurrent or Metastatic Nasopharyngeal Carcinom · Recurrent or Metastatic Nasopharyngeal C

#RecurrentorMetastaticNasopharyng#Antibody#Phase2#monoclonal-antibody#Seoul
Trials 1Status Active
AntibodyLimited DatastaleHenan Provincial People's Hospi…Preclinical

Gene evolution and molecular response under Bevacizumab treatment (Gene evolution and molecular response under Bevacizumab treatment)

Genetic Change · Genetic Change

#GeneticChange#Antibody#Preclinical#monoclonal-antibody#Henan
Trials 1Status Recruiting
AntibodyLimited DatastaleChangchun GeneScience Pharmaceu…Phase 1

Gentulizumab (Gentulizumab)

Solid Tumor; Non-Hodgkin Lymphoma · Solid Tumor

#SolidTumor#Antibody#Phase1#monoclonal-antibody#Non-HodgkinLymphoma+1
Trials 1Status Discontinued
AntibodyLimited DatastaleHookipa Biotech GmbHPhase 2

pembrolizumab (Keytruda, HB-202 / HB-201 alternating intravenous administration + pembrolizumab.)

HPV-Related Squamous Cell Carcinoma · HPV-Related Squamous Cell Carcinoma

#HPV-RelatedSquamousCellCarcinoma#Antibody#Phase2#monoclonal-antibody#Hookipa
Trials 1Status Active
AntibodyLimited DatastaleHanmi Pharmaceutical Company Li…Phase 1

HM95573, cetuximab (HM95573, cetuximab)

Locally Advanced Solid Tumor; Metastatic Solid Tumor · Locally Advanced Solid Tumor

#LocallyAdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#MetastaticSolidTumor+1
Trials 1Status Active
AntibodyLimited DatastaleChang Gung Memorial HospitalPreclinical

nivolumab (Opdivo, HNSCC patients have used Nivolumab)

HNSCC · HNSCC

#HNSCC#Antibody#Preclinical#monoclonal-antibody#Chang
Trials 1Status Active
AntibodyLimited DatastaleEli LillyPhase 2

HRS-7058 + Cetuximab (HRS-7058 + Cetuximab)

Advanced Malignant Tumour · Advanced Malignant Tumour

#AdvancedMalignantTumour#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Recruiting
AntibodyLimited DatastaleTaizhou Hanzhong biomedical co.…Phase 3

Pucotenlimab (HX008, HX008(Pucotenlimab))

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#monoclonal-antibody#Taizhou
Trials 1Status Recruiting
AntibodyLimited DatastaleShuhong YiPhase 2

atezolizumab (Tecentriq, Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab)

Recurrent Liver Cancer After Liver Transplantation · Recurrent Liver Cancer After Liver Trans

#RecurrentLiverCancerAfterLiverTr#Antibody#Phase2#monoclonal-antibody#Shuhong
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

trastuzuamb (Herceptin, Herceptin (trastuzuamb))

HER2 Positive Early or Locally Advanced Breast Cancer · HER2

#HER2#Antibody#Phase3#monoclonal-antibody#HER2PositiveEarlyorLocallyAdvanc+1
Trials 1Status Active

16 / 31 pages

← PreviousNext →